First Trust NYSE Arca Biotechnology Index Fund (FBT)

  • Loading...
#16

Best Fit Health/Biotechnology Funds ETFs

U.S. News evaluated 29 Health/Biotechnology Funds ETFs and 16 make our Best Fit list. Our list highlights the best passively managed funds for long-term investors. Rankings are assigned based on comparisons with Best Fit funds in this category.

How we identify Best Fit Funds

Best Fit Scorecard
Costs Typical
Tracking Error Good
Bid/Ask Ratio Good
Holdings Diversity Typical

Fund Description

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology Index(SM). The fund will normally invest at least 90% of its net assets plus the amount of any borrowings for investment purposes in common stocks that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. The fund is non-diversified.

Fund Snapshot Updated 04.14.2014

Previous Close Expense Ratio 0.60%
YTD Return 1.46% Avg. 30-Day Volume 264,586
1-Year Return 29.6% Market Cap Loading...
Bid $70.20 Shares Outstanding 15,200,000
Ask $70.22 Dividends $0.00
Top 10 Holdings
Myriad Genetics Inc (MYGN) 8.26%
Intermune Inc (ITMN) 8.18%
Alexion Pharmaceuticals Inc (ALXN) 5.51%
Regeneron Pharmaceuticals (REGN) 5.39%
Illumina Inc (ILMN) 5.25%
Cepheid (CPHD) 5.18%
Amgen Inc (AMGN) 5.16%
Biogen Idec Inc (BIIB) 5.10%
Techne Corp (TECH) 4.82%
United Therapeutics Corp Del (UTHR) 4.63%
% of Total Holdings 57.50%

Sector Breakdown

Geographic Breakdown

Best Fit Health/Biotechnology Funds

See full rankings for Health/Biotechnology Funds